| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.4.b^1
Agricola ZN et al. (2016)
|
Xla Wt + cebpa
NF21 (in situ hybridization)
|
|
|
|
Fig.3.b^1
Agricola ZN et al. (2016)
|
Xla Wt + spib MO
NF23 (in situ hybridization)
|
|
|
|
fig.5.p
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF18 (in situ hybridization)
|
|
|
|
|
fig.5.q
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF18 (in situ hybridization)
|
|
|
|
fig.6.p
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF20 (in situ hybridization)
|
|
|
|
|
fig.6.q
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF20 (in situ hybridization)
|
|
|
|
|
fig.5.p
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF21 (RT-PCR)
|
|
|
|
|
fig.5.q
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF21 (RT-PCR)
|
|
|
|
fig.7.e
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF22 (in situ hybridization)
|
|
|
|
|
fig.7.f
Costa RM et al. (2008)
|
Xla Wt + spib MO
NF22 (in situ hybridization)
|
|
|